St. Luke's Hospital, Chesterfield, Missouri
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, St. Luke's Hospital, Chesterfield, Missouri sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
St. Luke's Hospital, Chesterfield, Missouri: 6 sponsored US clinical trials, none currently recruiting.
St. Luke's Hospital, Chesterfield, Missouri sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Memory, with 1 trials.
Upper-quartile sponsor footprint
St. Luke's Hospital, Chesterfield, Missouri sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease
NCT02890888
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
NCT02232958
Hypnotic Medications and Memory: Effect of Drug Exposure During the Night
NCT01159652
Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP
NCT00901771
Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities
NCT00497432
Enhancing Slow Wave Sleep With Sodium Oxybate
NCT00506974
How the St. Luke's Hospital, Chesterfield, Missouri archive is shaped
6 indexed studies, none listed as recruiting (0% open); 4 completed (67%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Memory (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
St. Luke's Hospital, Chesterfield, Missouri: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
St. Luke's Hospital, Chesterfield, Missouri sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this St. Luke's Hospital, Chesterfield, Missouri page
6 registered trials is a research-attention snapshot, not an endorsement of St. Luke's Hospital, Chesterfield, Missouri or any single study.
- None of St. Luke's Hospital, Chesterfield, Missouri's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Memory is the condition St. Luke's Hospital, Chesterfield, Missouri studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Memory trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
St. Luke's Hospital, Chesterfield, Missouri pipeline card: 6 registered trials from official public datasets.Report a data error.